Search by Letter: ABCDEFGHIJKLMNOPQRSTUVWXYZ
/Home/Birth Control Pills Review/Dasetta 7/7/7 Review

Dasetta 7/7/7 Review


Dasetta 7/7/7 is a combination hormone medication which is used to prevent pregnancy. The drug contains 2 sex hormones: ethinyl estradiol and norethindrone.

Contents:

Indications for use

  • Hormonal contraception.

Mechanism of action

The drug works by preventing the release of an egg during your menstrual cycle. It also makes vaginal fluid thicker which does not allow sperm to reach an egg and changes the lining of the womb to prevent attachment of a fertilized egg. As a result, it passes out of the body.

Dosage and mode of application

Each pack of Dasetta 7/7/7 contains 28 tablets:

  • 7 light peach tablets each containing 0.5 mg of norethindrone and 0.035 mg of ethinyl estradiol;
  • 7 peach tablets each containing 0.75 mg of norethindrone and 0.035 mg of ethinyl estradiol;
  • 7 orange tablets each containing 1 mg of norethindrone and 0.035 mg of ethinyl estradiol;
  • 7 white tablets each containing only inert ingredients.

You should take tablets every day at about the same hour (at intervals not exceeding 24 hours).

You can take the first tablet on the first day of your menstrual bleeding or on the first Sunday after your menstrual bleeding begins. If you are a Sunday Start, you must use an additional method of contraception (condoms or spermicide) for the first 7 days of use (in the first cycle only.)

Take tablets for 28 days in a row, without any breaks. After you’ve taken the last inert tablet, start a new course of Dasetta 7/7/7 the next day.

After childbirth, you can start taking tablets 4 weeks postpartum (if you are NOT breastfeeding).

Overdose

Serious adverse reactions have not been reported following the intake of large doses of oral contraceptives. Overdosage symptoms may cause nausea and withdrawal bleeding (in females).

Side effects

Dasetta 7/7/7 side effects may include:

  • thrombophlebitis and venous thrombosis;
  • arterial thromboembolism;
  • pulmonary embolism;
  • myocardial infarction;
  • cerebral hemorrhage;
  • cerebral thrombosis;
  • hypertension;
  • gallbladder disease;
  • hepatic adenomas or benign liver tumors;
  • mesenteric thrombosis;
  • retinal thrombosis;
  • nausea;
  • vomiting;
  • gastrointestinal symptoms (abdominal cramps and bloating);
  • breakthrough bleeding;
  • spotting;
  • change in menstrual flow;
  • amenorrhea;
  • temporary infertility after discontinuation of treatment;
  • edema;
  • melasma which may persist;
  • breast changes: tenderness, enlargement, secretion;
  • change in weight;
  • change in cervical erosion and secretion;
  • migraine;
  • allergic reaction, including rash, urticaria, angioedema;
  • mental depression;
  • reduced tolerance to carbohydrates;
  • vaginal candidiasis;
  • change in corneal curvature;
  • intolerance to contact lenses;
  • pre-menstrual syndrome;
  • cataracts;
  • changes in appetite;
  • cystitis-like syndrome;
  • headache;
  • nervousness;
  • dizziness;
  • erythema multiforme;
  • paraesthesia;
  • visual impairment;
  • erythema nodosum;
  • vaginal infection;
  • urinary tract infection;
  • hemorrhagic eruption;
  • vaginitis;
  • porphyria;
  • impaired renal function;
  • hemolytic uremic syndrome;
  • acne;
  • changes in libido;
  • colitis;
  • Budd-Chiari Syndrome;
  • mood changes;
  • anxiety;
  • insomnia;
  • flatulence;
  • pancreatitis;
  • diarrhea;
  • hirsutism;
  • loss of scalp hair;
  • constipation;
  • diminution in lactation when given immediately postpartum;
  • cholestatic jaundice;
  • dysmenorrhea;
  • ovarian cyst;
  • vulvovaginal dryness;
  • benign breast neoplasm;
  • fibroadenoma of breast, breast cyst;
  • syncope;
  • convulsion;
  • dry eye;
  • vertigo;
  • tachycardia;
  • palpitations;
  • hot flush;
  • dyspnoea;
  • hepatitis;
  • night sweats;
  • pruritus;
  • muscle spasms;
  • pain in extremity;
  • myalgia;
  • back pain;
  • chest pain;
  • hyperhidrosis;
  • photosensitivity reaction;
  • asthenic conditions.

Adverse reactions caused by oral contraceptives are usually mild and tempory. They are more likely to occur during the first three months of use. If you have any severe negative effects caused by this drug, consult your doctor, You may need to stop using this medication and switch to an alternative method of birth control.

Contraindications

Do not take Dasetta 7/7/7 if you have any of the listed conditions:

  • hypersensitivity to ethinyl estradiol/norethindrone;
  • endometrial cancer;
  • benign or malignant hepatic tumors;
  • pregnancy;
  • major surgery, prolonged immobilization;
  • estrogen- or progestin-dependent cancer;
  • breast cancer;
  • smokers over the age of 35 or heavy smokers;
  • thrombogenic valvular;
  • active hepatic disease;
  • jaundice, OCP or pregnancy-associated;
  • thrombophlebitis;
  • thromboembolism;
  • rhythm heart disease;
  • CAD;
  • cerebrovascular disease;
  • thrombophilias;
  • persistent high blood pressure;
  • abnormal vaginal bleeding for an unknown reason;
  • SLE;
  • breastfeeding;
  • diabetes mellitus with vascular disease;
  • migraine headaches with or without aura.

Use with caution:

  • diabetes mellitus;
  • hepatic impairment;
  • renal disease;
  • HTN;
  • gallbladder disease;
  • sensitive to fluid retention;
  • depression hx;
  • vomiting or diarrhea;
  • hyperlipidemia;
  • inflammatory bowel;
  • obesity;
  • hereditary angioedema.

Interactions

If you use other medications at the same time, the effects of birth control pills may change. This may increase the risk of adverse reactions or cause the contraceptive not to work properly. Tell your doctor about all the drugs, vitamins, and herbal products you are currently taking, so that your doctor can help you prevent potentially dangerous drug interactions. Dasetta 7/7/7 may interact with the following medicines and products:

  • dicoumarol;
  • aminoglutethimide;
  • estrogens conjugated;
  • griseofulvin;
  • carbamazepine;
  • cyclosporine A;
  • hydrocortisone;
  • prednisolone;
  • rifampin;
  • phenobarbital;
  • phenytoin.

Pregnancy and breastfeeding

Do not use this medication in pregnancy. If you become pregnant or suspect that you may be pregnant, stop taking tablets immediately and consult your gynecologist immediately;

Do not use this medication if you are breastfeeding. Ethinyl estradiol and norethindrone may decrease the production of breast milk and change its composition.

What if I miss a pill?

  • If you miss 1 tablet in Weeks 1, 2, or 3, take it as soon as you remember;
  • If you miss two 2 tablets in Week 1 or Week 2, take 2 tablets the day you remember and 2 tablets the next day; then continue taking 1 tablet per day until the pack is empty. At the same time, you should use a back-up method of birth control if you have sex during the seven days after missing pills;
  • If you miss two 2 tablets in the Week 3 or misses 3 or more “active” tablets in a row, continue taking 1 tablet per day until Sunday, then throw out the remaining tablets and start a new pack that same day. At the same time, you should use a back-up method of birth control if you have sex during the seven days after missing pills;
  • If you miss any of the inert tablets in Week 4, just throw them away and keep taking 1 tablet per day until the pack is empty. You do not need a back-up method of birth control.

Precautions

  • The drug is not indicated for use in females who have not started menstrual periods yet;
  • If vomiting or diarrhea occurs within 4 hours after taking an active tablet, the contraceptive efficacy of the drug may decrease. in this case, it is necessary to continue taking tablets and use additional contraceptives until the end of this cycle;
  • Discontinue using Dasetta 7/7/7 if you have blood circulation disorders (pain and swelling of the extremities, pain behind the sternum (radiating to the left hand), difficulty breathing, prolonged and severe headache, loss of vision, numbness of body parts);
  • The risk of developing vascular disorders is higher in patients over the age of 35, as well as in women who smoke. The risk group also includes women with a family history of vascular disorders, obesity, impaired lipid metabolism, hypertension, heart defects, arrhythmia. Risk of developing vascular disorders may be associated with concomitant diseases and prolonged immobilization;
  • There is evidence of an increased risk of developing tumors when taking combination oral contraceptives, but in most cases, tumors were detected in the early stages (due to regular examinations of patients using birth control pills). Women taking Dasetta 7/7/7 have a slightly increased risk of cervical and breast cancer, as well as liver tumors. The drug reduces the risk of endometrial and ovarian cancer;
  • Before starting or resuming the use of this medication, it is necessary to consult a doctor and conduct a thorough medical examination and exclude pregnancy;
  • Women with a tendency to chloasma should avoid prolonged exposure to the sun and exposure to ultraviolet radiation as long as they use combination oral contraceptives;
  • In women with hereditary forms of angioedema, ethinyl estradiol may cause or worsen the symptoms of angioedema;
  • Women using birth control pills should consult a doctor every 6 months;
  • The medication can affect some laboratory parameters (liver, kidney, adrenal, thyroid, hemostasis levels, lipoprotein levels, transport proteins), so make sure all your doctors know that you are using COCs;
  • Women using Dasetta 7/7/7 may have irregular vaginal bleeding during the first few months. Use hygiene products and continue taking the tablets as usual;
  • Intermenstrual vaginal bleeding usually stops as your body adapts to the drug (usually after 3 months). If this bleeding continues, becomes heavy or resumes after termination, consult a doctor;
  • If you miss two menstruations in a row, consult a doctor immediately. Do not start taking pills from the next pack until the doctor excludes pregnancy;
  • This drug does not protect you from sexually transmitted diseases and is not used as emergency contraception;
  • The drug is not indicated for use after menopause;
  • Store at room temperature in a dry place, away from direct sunlight;
  • Keep out of reach of children.

Feedback Form

Name
Email
Rating
Review Content